Location History:
- Yongin-si, KR (2009 - 2016)
- Seoul, KR (2017)
- Hwaseong-si, KR (2022 - 2023)
Company Filing History:
3 out of 146 
2 out of 12 
2 out of 63 
Years Active: 2009-2025
Title: Chang Hee Park: Innovator in Pharmaceutical Chemistry
Introduction: Chang Hee Park is a notable inventor based in Yongin-si, South Korea, with an impressive portfolio of 8 patents. His contributions to pharmaceutical chemistry have significantly impacted the field, particularly through his recent innovations aimed at improving therapeutic compositions.
Latest Patents: Among Chang Hee Park's recent patents are two noteworthy inventions. The first is titled "Salts of 4-amino-N-(1-((3-chloro-2-fluorophenyl)amino)-6-methylisoquinolin-5-yl)thieno[3,2-D]pyrimidine-7-carboxamide, and crystalline forms thereof." This invention pertains to a crystalline form of a salt of the compound, which is beneficial in preparing pharmaceutical compositions containing the active ingredient. The second patent is for a "Pyrazole derivative compound and use thereof." This compound demonstrates inhibitory activity on lysine-specific demethylase-1 (LSD1) and is effective in preventing or treating diseases associated with the abnormal activation of LSD1.
Career Highlights: Chang Hee Park has made significant strides in the pharmaceutical industry, contributing to the development of effective therapeutic agents. His work has primarily been associated with prominent companies such as Hanmi Pharmaceutical Co., Ltd. and Hanmi Holdings Co., Ltd., where he has focused on innovative drug design and development.
Collaborations: Throughout his career, Chang Hee Park has collaborated with esteemed colleagues, including Tae Hee Ha and Hee Sook Oh. These partnerships have facilitated the advancement of his research and the successful patenting of innovative pharmaceutical solutions.
Conclusion: Chang Hee Park is a distinguished inventor whose work in pharmaceutical innovation is evident through his multiple patents. With a focus on enhancing drug development, his inventions continue to play a critical role in addressing significant medical challenges. As the pharmaceutical landscape evolves, Chang Hee Park remains a key figure in pioneering advancements for the benefit of global health.